← Back to Search

Behavioral Intervention

Reducing Exercise Sensitivity with Exposure Training for Acute Coronary Syndrome (RESET Trial)

N/A
Waitlist Available
Led By Andrea T Duran, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older.
Speak and read English.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and after pilot study completion (4 weeks)
Awards & highlights

RESET Trial Summary

This trial is testing a home-based exposure therapy intervention to help people with a history of ACS be less afraid of exercise sensations and improve participation in cardiac rehabilitation and physical activity.

Eligible Conditions
  • Acute Coronary Syndrome
  • Anxiety
  • Sedentary Lifestyle

RESET Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

RESET Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and after pilot study completion (4 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and after pilot study completion (4 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cephalopelvic Proportion
Proportion of participants that are adherent to the intervention (Intervention Adherence)
Proportion of participants who complete the outcome assessments upon program completion
+3 more
Secondary outcome measures
Change in Exercise Sensitivity Questionnaire Score
Change in self-reported physical activity and sitting

RESET Trial Design

1Treatment groups
Experimental Treatment
Group I: Reducing Exercise Sensitivity with Exposure TrainingExperimental Treatment1 Intervention
Participants in this group complete 2, at-home reducing exercise sensitivity with exposure training (RESET) intervention visits with research-trained personnel via video visits. They complete psychoeducation, and a brief walking activity (i.e., interoceptive exposure), followed by a session reflecting upon their walking experience with research-trained personnel (i.e., interoceptive counseling). Participants also complete weekly physical activity journals throughout the intervention. Each RESET intervention visits can occur once or twice per week over the course of 2 weeks, based on patient preference.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,655 Previous Clinical Trials
28,004,166 Total Patients Enrolled
2 Trials studying Acute Coronary Syndrome
549 Patients Enrolled for Acute Coronary Syndrome
Columbia UniversityLead Sponsor
1,424 Previous Clinical Trials
2,473,023 Total Patients Enrolled
9 Trials studying Acute Coronary Syndrome
3,747 Patients Enrolled for Acute Coronary Syndrome
Andrea T Duran, PhDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
40 Patients Enrolled for Acute Coronary Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment size for this research endeavor?

"Affirmative. Clinicaltrials.gov states that this clinical trial, initially posted on October 13th 2021, is actively seeking participants. Approximately 30 patients must be incorporated from one centre."

Answered by AI

Has enrollment in this clinical trial been opened up yet?

"Affirmative. According to clinicaltrials.gov, the trial which was originally posted on October 13th 2021 is still recruiting participants. A total of 30 individuals will be accepted from one medical site for this study."

Answered by AI
Recent research and studies
~1 spots leftby Mar 2025